Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Fish and Richardson
Boehringer Ingelheim
Daiichi Sankyo

Generated: January 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019261

« Back to Dashboard

NDA 019261 describes PAREMYD, which is a drug marketed by Akorn and is included in one NDA. It is available from one supplier. Additional details are available on the PAREMYD profile page.

The generic ingredient in PAREMYD is hydroxyamphetamine hydrobromide; tropicamide. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the hydroxyamphetamine hydrobromide; tropicamide profile page.
Summary for 019261
Ingredient:hydroxyamphetamine hydrobromide; tropicamide
Formulation / Manufacturing:see details
Pharmacology for NDA: 019261
Suppliers and Packaging for NDA: 019261
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PAREMYD hydroxyamphetamine hydrobromide; tropicamide SOLUTION/DROPS;OPHTHALMIC 019261 NDA Akorn, Inc. 17478-704 17478-704-12 1 BOTTLE, DROPPER in 1 CARTON (17478-704-12) > 15 mL in 1 BOTTLE, DROPPER

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION/DROPS;OPHTHALMICStrength1%;0.25%
Approval Date:Jan 30, 1992TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Johnson and Johnson
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.